Call for tenders for a study on innovation in the pharmaceutical sector

May 6, 2003

Brussels, 05 May 2003

The European Commission's Enterprise DG has published a call for tenders for a study on the levels of innovation in the European pharmaceutical sector.

The study will assess the reasons behind the significant drop in the number of marketing authorisations requested in 2002, looking back at the statistics from 1998 onwards, and forward to prospects for the next five years.

In particular, the study must provide answers to the following questions:
- Is innovation in the pharmaceutical sector in crisis worldwide?
- Are the reasons for the crisis economic, industrial or regulatory, or do they belong to another category?
- What tools are available for us to boost innovation?

The deadline for completing the study will be nine months from the date of the contract award notice.

For further information, please contact:
Mr Philippe Brunet, c/o Patrick Accart
European Commission
Directorate-General Enterprise, Unit F2
rue d'Arlon 88
B-1049 Brussels
Tel: +32-2-299-0031
Fax: +32-2-299-8046
E-mail: ENTR/F/2_PHARMACEUTIC_REGUL@cec.eu.int


To see the full details of the call, please consult the following web address:
http://ted.publications.eu.int/static/do ccur/en/en/76424-2003.htm
Remarks: The deadline for requesting tender documents is .5.2003.
The deadline for submitting tender documents is 3.6.2003.


Before contacting the Commission, tenderers are strongly advised to consult the original call text in the Official Journal of the European Communities at the reference below.

Document Reference: OJ No S 86-076424 of 03.05.2003

CORDIS RTD-NEWS / © European Communities

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments